Skip to main content
Sopharma Trading AD logo

Sopharma Trading AD — Investor Relations & Filings

Ticker · SFT ISIN · BG1100086070 LEI · 549300TWQWLJIPYNG883 BSOBGN Wholesale and retail trade
Filings indexed 31 across all filing types
Latest filing 2026-01-29 Annual Report
Country BG Bulgaria
Listing BSOBGN SFT

About Sopharma Trading AD

https://www.sopharmatrading.com/?lang=bg

Sopharma Trading AD is a leading, fully integrated provider of healthcare services specializing in the distribution of pharmaceutical products. The company engages in the wholesale and retail trade of medicinal products, drugs, and other healthcare items. It operates a network of modern distribution centers equipped with automated warehouse management systems to ensure comprehensive market coverage and efficient logistics. Serving the pharmaceutical sector, including pharmacies and hospitals, the company is a key distributor with a strong presence in Southeastern Europe. As part of the broader Sopharma Group, a major pharmaceutical manufacturer, it leverages group synergies to offer a wide portfolio of products and services to its customers.

Recent filings

Filing Released Lang Actions
676120-КФН_31.12.2025 годишни и шестмесечни справки на индивидуална основа.xlsx
Annual Report Classification · 95% confidence The document contains detailed financial data including a balance sheet (счетоводен баланс) for the company Софарма Трейдинг АД for the fiscal year starting 2025-01-01 and ending 2025-12-31, with a preparation date of 2026-01-30. The data includes assets, liabilities, equity, and other financial statement line items with current and prior period values. The length of the document is substantial (15,000 characters) and it contains actual financial statements and substantive financial data. The document is not a brief announcement or a certification but a full financial report for a full fiscal year. This matches the definition of an Annual Report (10-K) which covers company activity and full financial performance for the year. Therefore, the document should be classified as an Annual Report (10-K). FY 2025
2026-01-29 Norwegian Nynorsk
676119-FS Notes_SopharmaTrading_Q4.2025.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Interim Individual Financial Report' (Междинен индивидуален финансов отчет) for Sopharma Trading AD as of 31.12.2025. It contains detailed financial statements (Statement of Comprehensive Income, Statement of Financial Position, Cash Flow Statement, Statement of Changes in Equity) and extensive notes (Приложения) covering accounting policies, revenue, expenses, assets, liabilities, and risk management. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. FY 2025
2026-01-29 Bulgarian
610565-549300TWQWLJIPYNG883-20231231-BG-CON.xls
Regulatory Filings Classification · 19% confidence
2024-04-24 Bulgarian
549300TWQWLJIPYNG883-20231231-BG-CON.zip
Annual Report Classification · 100% confidence The document is a detailed consolidated financial report for the period ending December 31, 2023, including comprehensive financial statements such as the consolidated statement of comprehensive income, financial position, cash flows, and changes in equity. It includes extensive financial data, notes, and auditor information. The presence of full financial statements and detailed notes indicates this is a full annual report rather than a summary, announcement, or certification. The document is in Bulgarian but clearly labeled as a consolidated financial report for the year ending 2023, which aligns with the definition of an Annual Report (10-K). FY 2023
2024-04-24 Bulgarian
608404-Sopharma Trading_Scorecard_NCCG 2023.xls
Governance Information Classification · 19% confidence
2024-03-27 Bulgarian
608403-549300TWQWLJIPYNG883-20231231-BG-SEP.xls
Regulatory Filings Classification · 19% confidence
2024-03-27 Bulgarian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.